Skip to content

Clinical trials

Observational Gastrointestinal Neoplasms trials

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Gastrointestinal Neoplasms Phase: Observational Clear all

173 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20032
20052
20061
20076
20081
20106
20116
20125
20137
201412
20153
20165
20178
20185
201911
202016
202114
202212
202316
20249
202512
202612

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed69
Unknown status33
Recruiting31
Not yet recruiting12
Terminated11
Active, not recruiting9
Withdrawn5
Enrolling by invitation3

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
Exact Sciences Corporation6
National Cancer Institute (NCI)6
Hospices Civils de Lyon5
M.D. Anderson Cancer Center4
Peking University Cancer Hospital & Institute4
Royal Marsden NHS Foundation Trust4
Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins4
Ankara Etlik City Hospital3
Baylor College of Medicine3
Dr Abdurrahman Yurtaslan Ankara Oncology Training and Research Hospital3

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Gastrointestinal Neoplasms173
Colorectal Neoplasms38
Neoplasms35
Stomach Neoplasms28
Lung Neoplasms23
Breast Neoplasms21
Digestive System Neoplasms20
Gastrointestinal Diseases20
Pancreatic Neoplasms20
Digestive System Diseases16

Trials

Showing 51 to 75 of 173. Each trial links to its page on Pharma Observatory.

73 more trials match. See them on Pharma Observatory

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.